Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05985850Phase 2Recruiting

Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy

Role: lead

NCT06639373Recruiting

The Road to Recovery Initiative (R2RI)

Role: lead

NCT04815590Unknown

Extended-release Injectable Buprenorphine for Individuals at High Risk of Overdose

Role: lead

NCT02457949Not ApplicableTerminated

The Impact of Alternative Social Assistance Disbursement on Drug-related Harm

Role: collaborator

All 4 trials loaded